Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2026-01-02 @ 9:05 AM
Study NCT ID:
NCT03201250
Status:
TERMINATED
Last Update Posted:
2023-09-08
First Post:
2017-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
Sponsor:
University of Nebraska
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-19
First Submit QC Date:
None
Study First Post Date:
2017-06-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-07-15
Results First Submit QC Date:
None
Results First Post Date:
2022-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-25
Last Update Post Date:
2023-09-08
Last Update Post Date Type:
ACTUAL